Evaluating a technology-based reading intervention for children with reading disabilities
Effectiveness and Predictors of Intervention Response for a Technology-based Reading Intervention in the Home
This study is testing a new reading program called GraphoLearn to see if it can help children aged 6 to 10 with reading disabilities improve their skills at home.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 450 (estimated) |
| Ages | 6 Years to 10 Years |
| Sex | All |
| Sponsor | University of Connecticut Academic / other |
| Locations | 1 site (New York, New York) |
| Trial ID | NCT04568824 on ClinicalTrials.gov |
What this trial studies
This project conducts a large-scale randomized controlled trial to assess the effectiveness of GraphoLearn, a home-administered technology-based treatment for reading disabilities in children aged 6 to 10. The study will recruit 450 children with reading difficulties from the Healthy Brain Network, which provides extensive data on mental health and learning disorders. By comparing the GraphoLearn intervention to a control group receiving a math intervention, the researchers aim to determine the efficacy of this affordable and accessible reading intervention. The study addresses the limitations of current remedial approaches that often require specialist support, making it particularly relevant for under-resourced educational settings.
Who should consider this trial
Good fit: Ideal candidates for this study are children aged 6 to 10 who are enrolled in the Healthy Brain Network and have a reading efficiency score below 85.
Not a fit: Patients with vision or hearing impairments, severe autism, or other significant psychiatric or neurological disorders may not benefit from this study.
Why it matters
Potential benefit: If successful, this intervention could provide an effective, low-cost solution for improving reading skills in children with reading disabilities.
How similar studies have performed: Previous studies have shown promise for technology-based reading interventions, suggesting potential efficacy for approaches like GraphoLearn.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Must be 6.0 to 10.0 years old * Must be currently enrolled in Healthy Brain Network (HBN) * Must have a standard score \<85, on the Test of Word Reading Efficiency (TOWRE), Total Word Reading Efficiency (TWRE) composite * Must have full Scale IQ (FSIQ) on the Wechsler Intelligence Scale for Children (WISC V) \> 75 * Must be a native speaker of English Exclusion Criteria: * Vision or hearing impairment, per the Snellen Test and audiometer measurement * Moderate to severe autism (levels 2-3) * Major depressive disorder * Suicidal or homicidal ideation * Psychotic disorder * Manic episode * Any neurologic impairment that limits the ability to use a keyboard or mouse, or to touch a screen
Where this trial is running
New York, New York
- Child Mind Institute — New York, New York, United States (Recruiting)
Study contacts
- Principal investigator: Nicole Landi, PhD — University of Connecticut
- Study coordinator: Kayla Sirois
- Email: Kayla.Sirois@childmind.org
- Phone: 646.595.1677
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.